Cargando…
Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
Molecular heterogeneity in prostate cancer (PCa) is one of the key reasons underlying the differing likelihoods of recurrence after surgical treatment in individual patients of the same clinical category. In this study, we performed RNA-Seq profiling of 58 localized PCa and 43 locally advanced PCa t...
Autores principales: | Kobelyatskaya, Anastasiya A., Pudova, Elena A., Katunina, Irina V., Snezhkina, Anastasiya V., Fedorova, Maria S., Pavlov, Vladislav S., Kotelnikova, Anastasiya O., Nyushko, Kirill M., Alekseev, Boris Y., Krasnov, George S., Kudryavtseva, Anna V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253008/ https://www.ncbi.nlm.nih.gov/pubmed/37298233 http://dx.doi.org/10.3390/ijms24119282 |
Ejemplares similares
-
Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2021) -
Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
por: Pudova, Elena, et al.
Publicado: (2022) -
ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate Cancer
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2022) -
Lymphatic Dissemination in Prostate Cancer: Features of the Transcriptomic Profile and Prognostic Models
por: Pudova, Elena A., et al.
Publicado: (2023) -
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages
por: Pudova, Elena A., et al.
Publicado: (2021)